SEASTAR MEDICAL HOLDING CORPORATION - COMMON STOCK

SeaStar Medical Reports First Quarter 2025 Financial Results and Provides Business Updates

14 5 2025 13:05:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury

13 5 2025 05:05:00 提供 Nasdaq GlobeNewswire

SeaStar Medical to Report First Quarter Financial Results on May 14, 2025

07 5 2025 07:00:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Announces CEO Interview on Benzinga All Access to Occur Today at Approximately 10:50 am Eastern Time

30 4 2025 05:05:00 提供 Nasdaq GlobeNewswire

FDA Grants SeaStar Medical Two New Breakthrough Device Designations for SCD Therapy to Treat Systemic Inflammatory Response in Adult and Pediatric Patients Undergoing Cardiac Surgery

08 4 2025 05:05:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates

27 3 2025 13:05:00 提供 Nasdaq GlobeNewswire

SeaStar Medical to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025

24 3 2025 14:30:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Announces Closing of $6 Million Registered Direct Offering Priced At-the-Market

03 2 2025 13:05:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Announces $6 Million Registered Direct Offering Priced At-the-Market

31 1 2025 05:00:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Adds Fifth Hospital Customer for QUELIMMUNE

27 1 2025 05:00:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Activates 15th Site for its Adult Acute Kidney Injury Pivotal Trial

22 1 2025 04:30:00 提供 Nasdaq GlobeNewswire

FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome

13 1 2025 05:30:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Begins Shipping QUELIMMUNE to a Fourth Hospital Customer

08 1 2025 05:30:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Activates 14th Hospital for its Adult AKI Pivotal Trial

23 12 2024 04:00:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Projects Multibillion-Dollar Market Potential for its Selective Cytopheretic Device in Initial Target Indications

11 12 2024 03:30:00 提供 Nasdaq GlobeNewswire

SeaStar Medical to Hold Business Update Conference Call on December 11, 2024

04 12 2024 05:30:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Activates Sentara Norfolk General Hospital and Provides Enrollment Update in Adult AKI Pivotal Trial

03 12 2024 05:30:00 提供 Nasdaq GlobeNewswire

SeaStar Medical to Present at Noble Capital Markets’ NobleCon20 on December 4, 2024

26 11 2024 05:00:00 提供 Nasdaq GlobeNewswire

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Support SeaStar Medical’s Proposals to Ratify the Issuance of Shares and to Reduce the Number of Authorized Shares

22 11 2024 05:30:00 提供 Nasdaq GlobeNewswire

SeaStar Medical Reaches Milestone of 100th QUELIMMUNE Commercial Device as Shipments Begin to its Third Hospital Customer

15 11 2024 05:30:00 提供 Nasdaq GlobeNewswire